Summarized by Masters of Longevity from MedTech Dive.
FDA cleared a transcatheter device to close leaks around surgical replacement valves.
Key Takeaways
- The device is delivered via catheter through a leg artery or vein.
- A 200-patient PARADIGM trial reported supportive effectiveness data.
- Clinical evidence is from a single-arm study, so causation remains unproven.
